Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inmed Pharmaceuticals Inc (INM)

Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Inmed Pharmaceuticals Inc 1445 885 West Georgia St. VANCOUVER A1 V6C 3E8 CAN

www.inmedpharma.com Employees: 13 P: 604-669-7207 F: 778-945-6800

Description:

InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It engages in developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol in diseases with unmet medical need. InMed Pharmaceuticals Inc. is based in VANCOUVER, BC.

Key Statistics

Overview:

Market Capitalization, $K 3,037
Enterprise Value, $K -3,533
Shares Outstanding, K 718
Annual Sales, $ 4,600 K
Annual Net Income, $ -7,680 K
Last Quarter Sales, $ 1,270 K
Last Quarter Net Income, $ -1,680 K
EBIT, $ -5,340 K
EBITDA, $ -7,690 K
60-Month Beta 0.36
% of Insider Shareholders 1.85%
% of Institutional Shareholders 20.12%
Float, K 705
% Float 98.15%
Short Volume Ratio 0.69

Growth:

1-Year Return -38.83%
3-Year Return -99.45%
5-Year Return -99.85%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -54.20 on 11/14/24
Next Earnings Date 11/12/24
Earnings Per Share ttm -13.91
EPS Growth vs. Prev Qtr 28.68%
EPS Growth vs. Prev Year 82.17%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 11/14/24

INM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -65.74%
Return-on-Assets % -53.57%
Profit Margin % -166.96%
Debt/Equity 0.00
Price/Sales 0.68
Price/Cash Flow N/A
Price/Book 0.35
Book Value/Share 20.47
Interest Coverage -0.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar